These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 36192773)

  • 21. Transcriptomic analysis suggested the involvement of impaired lipid droplet biogenesis in graphene oxide-induced cytotoxicity in human umbilical vein endothelial cells.
    Luo Y; Wang X; Cao Y
    Chem Biol Interact; 2021 Jan; 333():109325. PubMed ID: 33221320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
    Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
    World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of serum free fatty acids and triglycerides by liver-targeted expression of long chain acyl-CoA synthetase 3.
    Wu M; Cao A; Dong B; Liu J
    Int J Mol Med; 2011 May; 27(5):655-62. PubMed ID: 21347510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity-Dependent Adipokine Chemerin Suppresses Fatty Acid Oxidation to Confer Ferroptosis Resistance.
    Tan SK; Mahmud I; Fontanesi F; Puchowicz M; Neumann CKA; Griswold AJ; Patel R; Dispagna M; Ahmed HH; Gonzalgo ML; Brown JM; Garrett TJ; Welford SM
    Cancer Discov; 2021 Aug; 11(8):2072-2093. PubMed ID: 33757970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of ACSL in local synthesis of neutral lipids in cytoplasmic lipid droplets in human hepatocyte HuH7.
    Fujimoto Y; Itabe H; Kinoshita T; Homma KJ; Onoduka J; Mori M; Yamaguchi S; Makita M; Higashi Y; Yamashita A; Takano T
    J Lipid Res; 2007 Jun; 48(6):1280-92. PubMed ID: 17379924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Characterization, Tissue Distribution Profile, and Nutritional Regulation of
    Yang Z; Zhu H; Huang X; Wang A; Xie D
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficiency of the X-inactivation escaping gene
    Zheng Q; Li P; Zhou X; Qiang Y; Fan J; Lin Y; Chen Y; Guo J; Wang F; Xue H; Xiong J; Li F
    Theranostics; 2021; 11(18):8674-8691. PubMed ID: 34522206
    [No Abstract]   [Full Text] [Related]  

  • 28. CX3CL1 promotes cell sensitivity to ferroptosis and is associated with the tumor microenvironment in clear cell renal cell carcinoma.
    Gong Q; Guo Z; Sun W; Du X; Jiang Y; Liu F
    BMC Cancer; 2022 Nov; 22(1):1184. PubMed ID: 36397015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction and validation of a novel ferroptosis-related prognostic signature for lung adenocarcinoma.
    Yang L; Fan X; Zhou C; Wang Z; Cui Z; Wu X; Xu Z; Yang J; Zhang X
    Transl Lung Cancer Res; 2023 Aug; 12(8):1766-1781. PubMed ID: 37691861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-4735-3p Facilitates Ferroptosis in Clear Cell Renal Cell Carcinoma by Targeting SLC40A1.
    Zhu C; Song Z; Chen Z; Lin T; Lin H; Xu Z; Ai F; Zheng S
    Anal Cell Pathol (Amst); 2022; 2022():4213401. PubMed ID: 35646516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AUP1 regulates lipid metabolism and induces lipid accumulation to accelerate the progression of renal clear cell carcinoma.
    Chen C; Zhao W; Lu X; Ma Y; Zhang P; Wang Z; Cui Z; Xia Q
    Cancer Sci; 2022 Aug; 113(8):2600-2615. PubMed ID: 35633317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting lipid biosynthesis on the basis of conventional treatments for clear cell renal cell carcinoma: A promising therapeutic approach.
    Guo T; Zhang X; Chen S; Wang X; Wang X
    Life Sci; 2024 Jan; 336():122329. PubMed ID: 38052321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Free docosahexaenoic acid promotes ferroptotic cell death via lipoxygenase dependent and independent pathways in cancer cells.
    Shan K; Feng N; Zhu D; Qu H; Fu G; Li J; Cui J; Chen H; Wang R; Qi Y; Chen YQ
    Eur J Nutr; 2022 Dec; 61(8):4059-4075. PubMed ID: 35804267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Chain Acyl-CoA Synthetase 4-Mediated Fatty Acid Metabolism Sustains Androgen Receptor Pathway-Independent Prostate Cancer.
    Ma Y; Zhang X; Alsaidan OA; Yang X; Sulejmani E; Zha J; Beharry Z; Huang H; Bartlett M; Lewis Z; Cai H
    Mol Cancer Res; 2021 Jan; 19(1):124-135. PubMed ID: 33077484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Ferroptosis-Related Genes Model Allows for Prognosis and Treatment Stratification of Clear Cell Renal Cell Carcinoma: A Bioinformatics Analysis and Experimental Verification.
    Wu J; Sun Z; Bi Q; Wang W
    Front Oncol; 2022; 12():815223. PubMed ID: 35155251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of Metallothionein 1 G (MT1G) Negatively Regulates Ferroptosis in Clear Cell Renal Cell Carcinoma by Reducing Glutathione Consumption.
    Zhang W; Luo M; Xiong B; Liu X
    J Oncol; 2022; 2022():4000617. PubMed ID: 36204178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of SETD2 promotes erastin-induced ferroptosis in ccRCC.
    Xue W; Jian W; Meng Y; Wang T; Cai L; Yu Y; Yu Y; Xia Z; Zhang C
    Cell Death Dis; 2023 Aug; 14(8):539. PubMed ID: 37604811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E2F1 promotes proliferation and metastasis of clear cell renal cell carcinoma via activation of SREBP1-dependent fatty acid biosynthesis.
    Shen D; Gao Y; Huang Q; Xuan Y; Yao Y; Gu L; Huang Y; Zhang Y; Li P; Fan Y; Tang L; Du S; Wu S; Wang H; Wang C; Gong H; Pang Y; Ma X; Wang B; Zhang X
    Cancer Lett; 2021 Aug; 514():48-62. PubMed ID: 34019961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hsa_circ_0086414/transducer of ERBB2 (TOB2) axis-driven lipid elimination and tumor suppression in clear cell renal cell cancer via perilipin 3.
    Meng X; Li W; Yu T; Lu F; Wang C; Yuan H; Yang W; Dong W; Xiao W; Zhang X
    Int J Biol Macromol; 2024 Mar; 261(Pt 1):129636. PubMed ID: 38272402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets.
    Tan SK; Hougen HY; Merchan JR; Gonzalgo ML; Welford SM
    Nat Rev Urol; 2023 Jan; 20(1):48-60. PubMed ID: 36192502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.